세계의 의료 영상 처리 분야 AI 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 용도별, 최종 용도별, 모달리티별, 지역별, 부문별 예측(2025-2033년)

AI In Medical Imaging Market Growth & Trends:

The AI in medical imaging market size is estimated to reach USD 19.78 billion by 2033, expanding at a CAGR of 34.67% from 2025 to 2033, according to a new report by Grand View Research, Inc, owing to the growing aging population and increased investment in the healthcare ecosystem by government and private players. Moreover, developed countries have been investing in offering people access to inexpensive and advanced healthcare systems in response to this demographic challenge, ultimately boosting the market growth. Additionally, X-ray imaging technology is utilized to identify a variety of disorders, including fractures, infections, various malignancies, and arthritis. As a result, the rise in the incidence rate of these diseases is expected to have a positive impact on the market growth.

COVID-19 had a positive impact on the market as the majority of medical professionals chose imaging as one of the most popular COVID-19 screening modalities as it provided critical diagnostic in a short time. The entire set of imaging data has been used to research the virus and its effect on people of various demographics. Many hospitals have resorted to medical imaging and image analytics techniques to improve the identification and control of the virus as nearly every healthcare organization is working to manage COVID-19 better and limit its spread. For instance, in June 2020, a hospital in Florida, the Tampa General Hospital employed AI-driven technology to check people for COVID-19 before they interacted with staff members and other patients.

The rising awareness regarding the benefits offered by Artificial Intelligence (AI) technologies and their application in the medical field has led to increased adoption of AI-based solutions, products, and services in the healthcare market. Moreover, to develop advanced AI-based applications for the healthcare industry, several leading healthcare companies are adopting different strategies such as collaborations, mergers & acquisitions, and partnerships with top AI technology vendors to provide cutting-edge solutions to their clients and strengthen their position in this competitive market environment. For instance, in June 2020, Intel announced its partnership with Maricopa County Community College District to introduce the first artificial intelligence associate degree in the North American region. The initiative will also be supported by a USD 100,000 workforce grant from the Arizona Commerce Authority. A number of students are expected to benefit from this partnership as it enables students to pursue employment in the automotive, technology, healthcare, and aerospace industries.

AI In Medical Imaging Market Report Highlights:

• Based on technology, the deep learning segment held the largest share of 57.67% in 2024 owing to its superior ability to analyze complex medical images and provide accurate diagnostics.
• Based on application, the neurology segment held the largest market share of 37.46% in 2024 owing to the increased use of AI in neurology, as it provides better patient care and enables higher accuracy and high efficiency.
• The CT scan segment held the largest market share of 34.86% in 2024 due to their ability to provide detailed cross-sectional images of the body making them indispensable in medical diagnostics.
• The hospitals segment dominated the market with the largest share of 52.64% in 2024 and is expected to grow at the fastest CAGR of over the forecast period.
• The AI in medical imaging market in North America dominated the global industry in 2023 and accounted for the largest revenue share of over 43.04% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Technology Segment
  • 1.2.2. Application Segment
  • 1.2.3. Modalities Segment
  • 1.2.4. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. AI in Medical Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. AI in Medical Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape
• 3.4. Case Study

Chapter 4. AI in Medical Imaging Market: Technology Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global AI in Medical Imaging Market Technology Movement Analysis
• 4.3. Global AI in Medical Imaging Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 4.4. Deep Learning
  • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.5. Natural Language Processing (NLP)
  • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI in Medical Imaging Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global AI in Medical Imaging Market Application Movement Analysis
• 5.3. Global AI in Medical Imaging Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Neurology
  • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. Respiratory and Pulmonary
  • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Cardiology
  • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Breast Screening
  • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Orthopedics
  • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Medical Imaging Market: Modalities Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global AI in Medical Imaging Market Modalities Movement Analysis
• 6.3. Global AI in Medical Imaging Market Size & Trend Analysis, by Modalities, 2021 to 2033 (USD Million)
• 6.4. CT Scan
  • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. MRI
  • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. X-rays
  • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Ultrasound
  • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Nuclear Imaging
  • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI in Medical Imaging Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global AI in Medical Imaging Market End Use Movement Analysis
• 7.3. Global AI in Medical Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. AI in Medical Imaging Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.2. Canada
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4.3. Mexico
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. UK
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.2. Germany
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.3. France
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.4. Italy
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.5. Spain
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.6. Norway
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.3. India
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.4. Australia
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.6. Thailand
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Brazil
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.2. Argentina
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 8.8. MEA
  • 8.8.1. South Africa
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.3. UAE
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.4. Kuwait
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. GE HealthCare
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Technology type benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Microsoft
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Technology type benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Digital Diagnostics Inc.
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Technology type benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. TEMPUS
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Technology type benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Butterfly Network, Inc.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Technology type benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Advanced Micro Devices, Inc.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Technology type benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. HeartFlow, Inc.
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Technology type benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Enlitic, Inc.
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Technology type benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Canon Medical Systems USA, Inc.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Technology type benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Viz.ai, Inc.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Technology type benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. EchoNous, Inc.
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Technology type benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. HeartVista Inc.
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Technology type benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. Exo Imaging, Inc
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Technology type benchmarking
    • 9.4.13.4. Strategic initiatives
  • 9.4.14. Nano-X Imaging Ltd.
    • 9.4.14.1. Company overview
    • 9.4.14.2. Financial performance
    • 9.4.14.3. Technology type benchmarking
    • 9.4.14.4. Strategic initiatives